Group One Trading, L.P. Surface Oncology, Inc. Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.61 - $1.03 $10,047 - $16,965	-16,471 Reduced 70.86%	6,774 $4,000
Q4 2022 Feb 09, 2023	SELL	$0.62 - $1.21 $8,291 - $16,182	-13,374 Reduced 36.52%	23,245 $19,000
Q3 2022 Nov 09, 2022	SELL	$1.05 - $2.1 $3,272 - $6,545	-3,117 Reduced 7.84%	36,619 $38,000
Q2 2022 Aug 11, 2022	BUY	$1.42 - $3.15 $56,425 - $125,168	39,736 New	39,736 $65,000
Q3 2021 Nov 12, 2021	SELL	$5.16 - $7.98 $52,719 - $81,531	-10,217 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$6.45 - $9.09 $65,899 - $92,872	10,217 New	10,217 $76,000
Q1 2021 May 12, 2021	SELL	$7.25 - $13.82 $98,440 - $187,647	-13,578 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$6.87 - $10.48 $93,280 - $142,297	13,578 New	13,578 $125,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.